Spine Firms Laud CMS’ Decision To Cover Percutaneous Lumbar Decompression In Trials

Spinal device makers, who objected to CMS’ proposal for outright noncoverage of percutaneous image-guided lumbar decompression, are pleased with the agency’s final decision to cover PILD when provided in a clinical study through coverage with evidence development.

Spinal device makers and other stakeholders that objected to CMS’ proposed noncoverage of percutaneous image-guided lumbar decompression (PILD) are pleased the agency has decided to offer coverage-with-evidence-development policy for PILD.

In its final national coverage decision on PILD

More from Clinical Trials

More from R&D